Microglia play an important role in inflammatory diseases of the central nervous system. There is evidence of microglial diversity with distinct phenotypes exhibiting either neuroprotection and repair or neurotoxicity. However the precise molecular mechanisms underlying this diversity are still unknown.
a b s t r a c t
Microglia play an important role in inflammatory diseases of the central nervous system. There is evidence of microglial diversity with distinct phenotypes exhibiting either neuroprotection and repair or neurotoxicity. However the precise molecular mechanisms underlying this diversity are still unknown.
Using a model of experimental autoimmune encephalomyelitis (EAE) we performed transcriptional profiling of isolated subventricular zone microglia from the acute and chronic disease phases of EAE. We found that microglia exhibit disease phase specific gene expression signatures, that correspond to unique gene ontology functions and genomic networks. Our data demonstrate for the first time, distinct transcriptional networks of microglia activation in vivo, that suggests a role as mediators of injury or repair.
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Introduction
The adult mammalian brain harbors neurogenic stem cells only within specialized compartments or niches (Doetsch, 2003) , such as the subventricular zone (SVZ) of the lateral wall or the subgranular zone (SGZ) of the hippocampal dentate gyrus. These areas are considered repositories of stem cell activity and plasticity, engage in tissue homeostasis (Carleton et al., 2003; Kohwi et al., 2005; Kosaka et al., 1995) , and promote repair after CNS injury (Corti et al., 2005; Imitola et al., 2004; Miller et al., 2005; Ohab et al., 2006; Robin et al., 2006) .
During the course of experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis (MS), neural stem cells (NSCs) in the SVZ show increased cellular activation during the acute phase (Rasmussen et al., in press) followed by significant decrease in proliferation and migration during the chronic phase of EAE (Pluchino et al., 2008) . Furthermore, alterations of the endogenous NSC compartment are not cell-autonomous but dependent on the SVZ microenvironment (Pluchino et al., 2008; Rasmussen et al., in press ).
The SVZ niche area is heterogeneous and in addition to stem/ progenitor cells, includes endothelial cells, that are considered bona fide niche cells that secrete products enabling stem cells to survive and maintain their identity (Shen et al., 2004) .
We have recently demonstrated that microglia populate the SVZ and proliferate during the acute phase of EAE showing marked activation, and remain activated during chronic disease (Rasmussen et al., 2007) suggesting that microglia can influence the SVZ microenvironment and impact the NSC compartment during EAE. We further showed that inactivating the microglia results in recovery of progenitor cell proliferation and enhanced repair (Rasmussen et al., in press ). In order to investigate whether microglia cells play a beneficial or detrimental role in EAE and particularly on the neural stem cell microenvironment during the course of EAE, we analyzed gene expression of isolated, flow sorted SVZ resident microglia during acute and chronic EAE followed by gene ontology (GO) and system-level network analysis. We identified independent genomic signatures of microglia from acute and chronic EAE: microglia display different sets of signature genes that are associated with a distinct impact on the SVZ microenvironment.
Material and methods

Animals and EAE induction
Female SJL/J were purchased from Jackson Laboratories Inc. (Bar Harbor, ME). Mice were housed in conventional, pathogen-free facility at the New Research Building, Harvard Medical School (Boston, MA). For induction of EAE, SJL/J mice were immunized with 150 lg of PLP139-151 (New England Peptide LLC, Gardener, MA, USA) as described previously (Rasmussen et al., 2007) . Clinical disease was assessed according to the following score: 0, no disease; 1, loss of tail tone; 1.5, poor righting ability; 2, hind limb weakness; 3, hind limb paralysis; 4, hind limb paralysis and fore limb weakness; 5, moribund. The mice were sacrificed at different time points according to the disease phase and clinical score. Acute EAE was defined as peak of disease (around 13 days post immunization, dpi) when mice
